Gen Z may have grown up online, but new reports and cybersecurity experts say younger internet users are becoming ...

One of the products advertised for weight loss contained a drug that was taken off the market in the United States because it raised the risk of heart attack and stroke in some people.

Credit: Getty Images This literature review supports the use of metformin as an effective and safe treatment alternative to insulin for pregnant women with gestational diabetes. Another option for ...

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...

Jelly Roll is opening up about what it took to lose nearly 300 lbs. In an interview with Men’s Health published in January 2025, he explained, “I just remember everyone telling me GLP-1s, or taking ...

With buzzy medications like Ozempic and Mounjaro making headlines for blood sugar management, it’s easy to forget that some medications have been helping patients with type 2 diabetes for decades.

A Garvan Institute of Medical Research-led clinical trial has found that using the type 2 diabetes (T2D) drug metformin reduces insulin needs in type 1 diabetes (T1D), a finding that could potentially ...

Metformin blunted exercise-induced improvements in vascular insulin sensitivity, aerobic fitness, inflammatory markers, and fasting glucose levels in adults at high risk for metabolic syndrome, ...

Rutgers scientists found that metformin can blunt many of the metabolic and cardiovascular improvements normally produced by exercise. Participants who took the drug saw reduced gains in fitness, ...

Share on Pinterest Metformin may weaken the benefits of exercise, a new study suggests. Image credit: huzu1959/Getty Images About one in every nine adults worldwide has diabetes, and 90% of those ...

Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma The Metformin Active Surveillance Trial (MAST) was a multicenter, randomized, double-blind, placebo-controlled phase III trial ...